Cancer Biological Therapy Market Trends

Cancer Biological Therapy Market Drivers

Increasing Concerns to Monitor Cancer Cases

• The increasing number of cancer cases worldwide is a significant driver fueling the growth of the global cancer biological therapy market during the forecast period. According to reports from the American Cancer Society, there has been a notable rise in Small Cell Lung Cancer (SCLC) cases, with a majority occurring in individuals between the ages of 60 and 80 years. The estimated global death rate from SCLC is approximately 30,000 per year. Additionally, data from the World Health Organization (WHO) reveals that lung cancer ranks as the second most prevalent cancer in both men and women, causing 1.59 million deaths in 2012. These alarming statistics contribute to the surge in demand for cancer biological therapies, propelling market growth to address the increasing burden of cancer on a global scale.

Cancer Biological Therapy Market Restraints

High Cost Of Treatment

• The significant cost associated with cancer treatment methods poses a considerable challenge to the growth of the market. Many of these treatments come with high expenses, making it difficult for a considerable number of people, especially those in rural areas, to afford them. This financial burden acts as a major hindrance to market growth.